We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ANGO

Price
10.02
Stock movement down
-0.06 (-0.66%)
Company name
AngioDynamics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Markedsværdi
368.55M
Ent værdi
410.59M
Pris/omsætning
1.26
Pris/bog
1.87
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
73.46%
1 års afkast
19.34%
3 års afkast
-27.58%
5 års afkast
-0.56%
10 års afkast
-4.82%
Senest opdateret: 2025-09-12

iO Charts is a Seeking Alpha partner

UDBYTTE

ANGO betaler ikke udbytte

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning1.26
Pris til egenkapital1.87
EV i forhold til salg1.40

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier40.63M
EPS (TTM)-5.98
FCF pr. aktie (TTM)-0.78

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)292.73M
Bruttofortjeneste (TTM)145.50M
Driftsindkomst (TTM)-43.62M
Nettoindkomst (TTM)-243.03M
EPS (TTM)-5.98
EPS (1 år frem)-0.23

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)49.71%
Driftsmargin (TTM)-14.90%
Fortjenstmargin (TTM)-83.02%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter55.01M
Nettotilgodehavender39.56M
Omsætningsaktiver i alt172.59M
Goodwill0.00
Immaterielle aktiver75.77M
Ejendomme, anlæg og udstyr0.00
Sum aktiver293.63M
Kreditor31.27M
Kortfristet/nuværende langsigtet gæld4.80M
Summen af kortfristede forpligtelser76.70M
Sum gæld97.05M
Aktionærernes egenkapital196.58M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)-20.51M
Investeringsudgifter (TTM)11.08M
Fri pengestrøm (TTM)-31.60M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-123.63%
Afkast af aktiver-82.77%
Afkast af investeret kapital-122.43%
Kontant afkast af investeret kapital-15.92%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning9.04
Daglig høj9.19
Daglig lav8.94
Daglig volumen283K
Højeste gennem alle tider31.07
1 års analytiker estimat18.25
Beta0.67
EPS (TTM)-5.98
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation1 Oct 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
ANGOS&P500
Nuværende prisfald fra top notering-70.81%-1.46%
Højeste prisfald-83.04%-56.47%
Højeste efterår dato25 Mar 20249 Mar 2009
Gennemsnitlig fald fra toppen-47.20%-10.99%
Gennemsnitlig tid til nyt højdepunkt243 days12 days
Maks. tid til nyt højdepunkt4860 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
ANGO (AngioDynamics Inc) company logo
Markedsværdi
368.55M
Markedsværdi kategori
Small-cap
Beskrivelse
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Personale
675
Investor relationer
-
SEC-indsendelser
Adm. direktør
James Christopher Clemmer
Land
USA
By
Latham
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...